EUVIMEDEUVIMED entdecken
Crossref

Evolutionary adaptation and asymmetric inheritance of polyploid giant cancer cells in esophageal squamous cell carcinoma

Qiqin Song, Mingwei Gao, Yongjia Weng, Xuehan Zhuang, Yueguang Wu, Heyang Cui, Ning Ding, Longlong Wang, Shanshan Bi, Li Zhang, Weimin Zhang, Yongping Cui

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.217818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Qiqin Song und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Shenzhen, 518035, PR Chin…. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Polyploidy, Esophageal Neoplasms, Giant Cells. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polyploid Giant Cancer Cells (PGCCs) play a critical role in tumor progression due to their distinctive biological behaviors. However, the mechanisms by which PGCCs regulate their composition and structure to adapt to dynamic environments during their formation remain poorly understood. In this study, we used multicolour labeling of major organelles in esophageal squamous cell carcinoma (ESCC) cells combined with high- and super-resolution time-lapse imaging to monitor induced PGCCs in three dimensions. In addition to abnormal PGCC division, we observed nuclear dynamics and transient cell-in-cell formations. PGCCs exhibited cell cycle abnormalities, including prolonged G1/S transitions, asynchronous micronuclei, and intranuclear mitosis. Notably, early progeny continued dividing despite cell cycle dysregulation, resulting in asymmetric offspring. Quantitative analysis of subcellular structures revealed asymmetric inheritance of organelles, particularly mitochondria and the Golgi apparatus, in recurrent cells. These adaptive mechanisms in PGCCs may also be relevant in the context of anticancer treatments, contributing to the heterogeneity of recurrent tumours arising from early PGCC progeny populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaPolyploidyEsophageal NeoplasmsGiant CellsHumansCell Line, TumorMitosisMitochondriaCell Cycle

Stichwörter der Autor:innen

Asymmetric inheritanceCell cycle abnormalitiesESCCNuclear dynamicsPGCCs

Autor:innen und Institutionen

  • Cancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Shenzhen, 518035, PR China; Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen, 51…
  • Cancer Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Shenzhen, 518035, PR China.
  • Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, 999077, SAR, Hong Kong, China.
  • Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen, 518000, PR China.

Zitieren

APA

Song, Q., Gao, M., Weng, Y., Zhuang, X., Wu, Y., Cui, H., Ding, N., Wang, L., Bi, S., Zhang, L., Zhang, W., & Cui, Y. (2025). Evolutionary adaptation and asymmetric inheritance of polyploid giant cancer cells in esophageal squamous cell carcinoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217818

Vancouver

Song Q, Gao M, Weng Y, Zhuang X, Wu Y, Cui H, et al. Evolutionary adaptation and asymmetric inheritance of polyploid giant cancer cells in esophageal squamous cell carcinoma. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217818

BibTeX
@article{Song2025,
  author = {Song, Qiqin and Gao, Mingwei and Weng, Yongjia and Zhuang, Xuehan and Wu, Yueguang and Cui, Heyang and Ding, Ning and Wang, Longlong and Bi, Shanshan and Zhang, Li and Zhang, Weimin and Cui, Yongping},
  title = {Evolutionary adaptation and asymmetric inheritance of polyploid giant cancer cells in esophageal squamous cell carcinoma},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.217818}
}
Kostenlos starten →